专栏名称: 同写意
一个以新药创制为核心,汇集国内一流研发精英的大型交流与价值分享平台。“同筑技术人生路,写意中国新药魂”是同写意的初衷与愿景。秉承汇集“一线、一流”,讲求“实用、实在、时效”的原则。
目录
相关文章推荐
禽报网  ·  企业\\同比大增120%!新希望2024年预 ... ·  22 小时前  
禽报网  ·  鸡报•2-8\\毛鸡乱,3.0-3.4都有; ... ·  22 小时前  
51好读  ›  专栏  ›  同写意

【直播】BioSpark Monthly News: 2024年十二月生物医药大事讨论

同写意  · 公众号  ·  · 2025-01-02 19:28

正文


各领域专家汇聚在BioSpark Monthly News论坛,交流过去一个月发生的 生物医药领域大事件





本月热点

TOPICS

1 . Oncology & Autoimmune Diseases:

  • Arcellx’s BCMA CAR-T challenges Legend’s Carvykti in multiple myeloma ;

  • Eli Lilly's Imlunestrant, an oral SERD, significantly improved PFS in ER+, HER2- advanced breast cancer patients;

  • Merck/VelosBio’s ROR1-directed ADC on top of R-CHP showed 100% ORR in 1L DLBCL, with safety signals to inform Phase 3 study of the low dose;

  • BMS’ TYK2 inhibitor Sotyktu succeeds in two phase 3 trials of psoriatic arthritis;


2 . New Modalities:

  • Merus’ petosemtamab showed standard-of-care potential in 2L+ HNSCC while its zenocutuzumab received FDA accelerated approval to treat NRG1 fusion-positive NSCLC and pancreatic adenocarcinoma;

  • Janux Therapeutics’ JANX007 showed promising interim phase 1a data in patients with advanced prostate cancer;


3 . Metabolic & Neurological Diseases:

  • Novo Nordisk’s CagriSema showed 22.7% weight loss in a phase 3 obesity trial, falling short of high expectations;

  • AbbVie announced positive topline results for the third phase 3 trial of Tavapadon in Parkinson’s Disease;

  • Novartis pays $1B upfront for PTC518, a phase 2 oral drug for Huntington’s Disease;

  • BMS pays $100M upfront to collaborate with BioArctic on Alzheimer’s drugs.



活动详情


主题: Monthly biotech news discussion - December 2024 in review


时间: 2025年1月4日 Sat 8:00 PM(EST)/ 2025年1月5日 周日 早上9:00 AM(北京时间)


地点: zoom meeting(扫描二维码 获得zoom注册链接 或点击文末“阅读原文”


嘉宾

Jimmy Wang (王俊) , Assistant Professor @ New York University

( https://www.linkedin.com/in/jun-jimmy-wang-69a16a58/ )


Ethan Xu (徐亦迅), VP of Bioinformatics @ Aspen Neuroscience

( http://linkedin.com/in/ethan-yixun-xu-2b915a4 )


Yanran He (何嫣然 ), Investment Director @ Sinopharm-CICC

( https://www.linkedin.cn/injobs/in/yanranhe )


Stephen Yan (严顺飞) , BD Search & Evaluation @ AstraZeneca

( https://www.linkedin.com/in/shunfei-yan/ )


Xianbo Zhou (周显波) , Founder & CEO @ AstraNeura

( https://www.linkedin.com/in/xianbo-zhou-7b33b76/ )


Avery Yan (晏庆红) , Founder & CEO @ Riboway Therapeutics

( https://www.linkedin.com/in/avery-yan/ )


Lihua Yu (于利华) , Chief Data Officer @ Fogpharma

( https://www.linkedin.com/in/lihua-yu-5b3337 )


Leon 'Jun' TANG (唐钧), Founding Partner @ InScienceWeTrust BioAdvisory

( https://www.linkedin.com/in/leontangnyc/ )


Yongjiang Hei (黑永疆) , Co-CEO @ Biocity Biopharma

( http://linkedin.com/in/yonghei )


Wenjun Wu (Armstrong, 吴文君), Director @ HanKang Venture

( https://www.linkedin.com/in/文君-吴-14787b95/ )


本期活动组织: Ethan Xu

本月热点总结:Armstrong和monthly news嘉宾




活动直播伙伴















请到「今天看啥」查看全文